作者: Fray F. Marshall , Harry F. Klinefelter
DOI: 10.1016/0090-4295(79)90526-0
关键词: Malignant disease 、 Drug 、 Rheumatoid arthritis 、 Low dose cyclophosphamide 、 Cyclophosphamide therapy 、 Internal medicine 、 Immunology 、 Hemorrhagic cystitis 、 Low dosage 、 Medicine 、 Cyclophosphamide 、 Gastroenterology
摘要: Hemorrhagic cystitis is a recognized acute complication of cyclophosphamide (Cytoxan) therapy in the treatment malignant disease. More recently, lower dose, long-term has been used autoimmune diseases including rheumatoid arthritis. In 3 patients hemorrhagic developed after for Even low dosage, this drug may cause cystitis.